Capstone Investment Advisors’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$934K Sell
36,500
-23,500
-39% -$553K ﹤0.01% 981
2026
Q1
$898K Sell
60,000
-190,000
-76% -$3.24M ﹤0.01% 902
2025
Q4
$3.64M Sell
250,000
-4,185,000
-94% -$73M 0.01% 443
2025
Q3
$79.6M Buy
4,435,000
+4,290,900
+2,978% +$62.9M 0.15% 70
2025
Q2
$2.46M Sell
144,100
-90,900
-39% -$910K 0.01% 578
2025
Q1
$1.7M Buy
235,000
+200,000
+571% +$2.28M ﹤0.01% 728
2024
Q4
$492K Sell
35,000
-20,000
-36% -$295K ﹤0.01% 1324
2024
Q3
$652K Buy
55,000
+29,230
+113% +$303K ﹤0.01% 1113
2024
Q2
$240K Sell
25,770
-60,934
-70% -$311K ﹤0.01% 1697
2024
Q1
$307K Buy
+86,704
New +$301K ﹤0.01% 1828

Other funds holding CORZ

Capstone Investment Advisors's CORZ Position: Q2 2026 in Review

Capstone Investment Advisors reduced its Core Scientific (CORZ) stake by 39% in Q2 2026, selling an estimated $553K and leaving 36,500 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Capstone Investment Advisors first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $79.6M in Q3 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Capstone Investment Advisors held 36,500 shares of Core Scientific worth $934K as of Q2 2026.
  • Capstone Investment Advisors sold 23,500 Core Scientific shares in Q2 2026, an estimated $553K.
  • Core Scientific made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #981 holding.
  • Capstone Investment Advisors first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Capstone Investment Advisors's Core Scientific position peaked at $79.6M in Q3 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.